findmyKOL
Clinical trialNCT03225924TerminatedPhase 1/PHASE2Interventional

Study of Entospletinib (ENTO) in Newly Diagnosed DLBCL Patients With aaIPI>=1 Treated by Chemiotherapy

SponsorThe Lymphoma Academic Research OrganisationEnrollment25DLBCL
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Clinique Universite Catholique de Louvain Saint-Luc

    Brussels, Belgium

  • Institut Jules Bordet

    Brussels, Belgium

  • University Hospital Gent

    Ghent, Belgium

  • Hopital Joliment

    Haine-Saint-Paul, Belgium

  • Az Groeninge

    Kortrijk, Belgium

  • Ucl Namur

    Yvoir, Belgium

France
  • Ch de Bourg En Bresse

    Bourg-en-Bresse, France

  • Chu Côte de Nacre

    Caen, France

  • Chu Henri Mondor

    Créteil, France

  • Chu de Dijon

    Dijon, France

  • Ch de Versailles - Hopital Andre Mignot

    Le Chesnay, France

  • Clinique Victor Hugo

    Le Mans, France

  • Chu de Limoges - Hopital Dupuytren

    Limoges, France

  • Chu Lyon Sud

    Lyon, France

  • Clinique de la Sauvegarde

    Lyon, France

  • Chu Montpellier

    Montpellier, France

  • Ch Region Mulhouse Et Sud Alsace

    Mulhouse, France

  • Hopital Necker Paris

    Paris, France

  • Chu de Bordeaux

    Pessac, France

  • Ch Annecy Genevois

    Pringy, France

  • Chu de Reims - Hopital Robert Debre

    Reims, France

  • Chu de Rennes - Pontchaillou

    Rennes, France

  • Ch de Roubaix-Hopital Victor Provo

    Roubaix, France

  • Iuct Oncopole de Toulouse

    Toulouse, France

  • Hôpital Bretonneau- Centre H. Kaplan

    Tours, France

  • Ch de Valenciennes

    Valenciennes, France

  • Chru de Nancy

    Vandœuvre-lès-Nancy, France

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Jul 2017
Primary completion
18 Oct 2019
Completion
18 Oct 2019
Last update posted
2 Sept 2020
Registered enrollment
25
Registry id
NCT03225924

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.